Hosted on MSN10mon
AstraZeneca follows rival, will cap inhaler prices at $35 per month amid scrutiny
including five of AstraZeneca’s patents on its blockbuster inhaler Symbicort. The company noted it reduced the list price of Symbicort at the start of this year. The change comes amid increasing ...
pharmaphorum3y
AstraZeneca breathes sigh of relief as court blocks US Symbicort generic
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...
Healio6h
Metered-dose to dry-powder inhaler switch not often reversed in veterans
A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...
ndtvprofit10d
AstraZeneca Pharma Gets Nod To Import New Drug Eculizumab
The pact with Mankind Pharma, announced in March 2024, was an exclusive agreement for distribution of budesonide and formoterol fumarate dihydrate drug under the brand name of Symbicort, which is a ...
pharmaphorum7y
AZ boosted by COPD triple inhaler results
AstraZeneca may mount a challenge ... administered by a pressurised metered-dose inhaler, with Bevespi Aerosphere and Symbicort Turbohaler, as well as PT009 – a combination of budesonide ...